PDL Biopharma
PDLI
#8050
Rank
HK$2.19 B
Marketcap
HK$19.21
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -HK$1.03 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are HK$80.61 Million. In 2019 the company made an earning of -HK$0.49 Billion a decrease over its 2018 earnings that were of -HK$0.35 Billion.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-HK$1.03 Billion111.07%
2019-HK$0.49 Billion42.43%
2018-HK$0.35 Billion-121.38%
2017HK$1.59 B60.41%
2016HK$0.99 B-77.09%
2015HK$4.33 B3.09%
2014HK$4.20 B26.65%
2013HK$3.31 B19.82%
2012HK$2.76 B3.68%
2011HK$2.67 B77.17%
2010HK$1.50 B-35.29%
2009HK$2.33 B23.45%
2008HK$1.88 B-1751.42%
2007-HK$0.12 Billion-88.56%
2006-HK$1 Billion93.73%
2005-HK$0.52 Billion13.63%
2004-HK$0.46 Billion32.12%
2003-HK$0.35 Billion87.44%
2002-HK$0.19 Billion-302.45%
2001HK$90.49 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Compugen
CGEN
-HK$0.22 Billion-79.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$64.11 B-6,366.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$0.89 Billion-13.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.00 B-17,205.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$0.85 Billion-17.13%๐Ÿ‡บ๐Ÿ‡ธ USA